Cite
HARVARD Citation
Mollica, V. et al. (2018). A case of complete response to nivolumab after long-term progression-free survival with tyrosine kinase inhibitor. Anti-cancer drugs. 29 (9), p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Mollica, V. et al. (2018). A case of complete response to nivolumab after long-term progression-free survival with tyrosine kinase inhibitor. Anti-cancer drugs. 29 (9), p. . [Online].